Navigation Links
ClearLight Diagnostics and Researchers at the Indiana University's Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
Date:5/3/2017

SUNNYVALE, Calif., May 3, 2017 /PRNewswire/ -- ClearLight Diagnostics, LLC, (ClearLight) a developer of a next generation tissue processing and 3D imaging platform, announced today that it has signed a collaboration agreement with the Indiana University Melvin and Bren Simon Cancer Center to study the tumor microenvironment in patients with breast cancer. Working with researchers in the Department of Pathology and Clinical Medicine, ClearLight will use the CLARITY method and 3D imaging to map key aspects of the microenvironment of breast cancer tumors.  Using CLARITY, the heterogeneity of both the tumor and the tumor microenvironment can be better understood in solid tumors due to the elucidation of 3D spatial information versus analysis by standard 2D, thin section tissue processing methods. Profiling 3D aspects of breast cancer tumor tissue is particularly valuable relative to the analysis of tumor-infiltrating lymphocytes (TILs) and their clinical value for patients. Several independent studies have demonstrated that TILs are prognostic in breast cancer, with the potential to demonstrate relevance for response to immune-checkpoint inhibitor therapy. Phenotyping TILs and characterizing the spatial relationships of the vasculature as well as key standard of care tumor biomarkers will create a new knowledge base for capturing the heterogeneity of breast cancer tissue.

"We are very fortunate to be working with a world-class team of investigators who have made practice changing contributions to the field of translational cancer research as well as clinical treatment practice," said Laurie Goodman, Ph.D., Chief Scientific Officer at ClearLight Diagnostics.  "This collaboration is key to the advancement of the analytic and eventual clinical development of our platform."

"We are excited to apply this revolutionary technology to a variety of preclinical and clinical models of breast cancer that are important to our clinical research program. These will greatly assist developing novel biomarker based therapies for our patients," said Sunil Badve, MD, Joshua Edwards Professor of Pathology & Laboratory Medicine and Director of the Translational Genomics Core.  

The collaboration between ClearLight and Indiana University School of Medicine demonstrates a commitment to convert research discovery to clinical application.

About ClearLight Diagnostics

ClearLight Diagnostics is a technology development company focused on the discovery, development, and commercialization of innovative technologies to significantly improve the diagnosis and treatment of a wide range of diseases with an initial focus in oncology. Founded by Karl Deisseroth MD, PhD, ClearLight is developing a product platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University. This technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The process produces a fully assembled, intact tissue, which is permeable to macromolecules and optically transparent, thus allowing for robust three-dimensional imaging of subcellular components (DNA, RNA and protein) and heterogeneous cellular interactions within the tumor microenvironment.  This technology, paired with the development of a tissue imaging platform that includes the revolutionary microscopy method, COLM (CLARITY Optimized Light-sheet Microscopy) will enable unprecedented depth and acceleration of image collection from lipid-cleared samples interrogated with biomolecules.  Visit www.clearlightdx.com.

Contact:

Laurie Goodman, PhD

5104705042

157798@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clearlight-diagnostics-and-researchers-at-the-indiana-universitys-melvin-and-bren-simon-cancer-center-announce-a-collaboration-to-profile-the-tumor-microenvironment-in-patients-with-breast-cancer-300450540.html


'/>"/>
SOURCE Clearlight Diagnostics, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
2. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
3. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
4. Dominion Diagnostics to Sponsor 2013 Addiction Professional Panel Series as Thought Leadership Partner
5. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
6. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
7. Advanced Animal Diagnostics Raises $6 Million for On-farm Diagnostics
8. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing
9. TrueVision® 3D Surgical and i-Optics Announce Collaboration to Integrate Diagnostics and Computer-Guidance in Cataract Surgery
10. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
11. BioConference Live Lands CMO of Roche Diagnostics and Other High Level Speakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time in ... STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, ... , US2020’s mission is to change the trajectory of STEM education in America ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):